Weekly Fungal Diagnostics Update (April 2026)
Last reviewed: April 2026
Key Points
- Rapid molecular diagnostics (PCR, LAMP, metagenomic sequencing) are expanding quickly.
- No single test is sufficient—combining approaches remains essential.
- Biomarker performance in real-world settings is variable.
- Traditional diagnostics still play a key role but have important limitations.
Overview
This week’s research highlights a clear trend: fungal diagnostics are becoming faster and more sensitive, but also more complex to interpret.
Many newer tests detect fungal material very effectively—but distinguishing infection from colonisation remains a major challenge.
Molecular Diagnostics (PCR, LAMP, mNGS)
Multiplex PCR for respiratory fungal infections
A multiplex PCR assay detected Aspergillus, Histoplasma, and Pneumocystis from sputum in patients with tuberculosis-like symptoms.
LAMP for Candida auris
A loop-mediated isothermal amplification (LAMP) assay showed high sensitivity for detecting Candida auris, in some cases outperforming PCR.
Metagenomic sequencing (mNGS)
Metagenomic next-generation sequencing improved detection of mixed and rare fungal infections in eye samples.
Take-home messages:
- Molecular tests can detect fungi earlier and more broadly than traditional methods.
- mNGS is particularly useful for complex or mixed infections.
- However, detecting fungal DNA does not always mean active disease.
Biomarkers and Antigen Testing
Beta-D-glucan and Candida biomarkers (ICU setting)
A large ICU study found that beta-D-glucan, antigen, and antibody tests had limited diagnostic accuracy, even when combined.
Cryptococcal antigen lateral flow testing
A multicentre study showed generally good performance but variability depending on sample type.
Take-home messages:
- Biomarkers remain useful but are not definitive on their own.
- Test performance varies by patient group (e.g. ICU vs outpatient).
- Combining biomarkers does not always improve accuracy.
Laboratory Identification and Routine Testing
Real-world Candida auris diagnostics
Hospitals use a range of approaches including MALDI-TOF and susceptibility testing, with variation between centres.
Rapid phenotypic identification vs PCR
Rapid lab-based tests for Candida albicans remain useful but require validation against molecular methods.
Limits of microscopy and morphology
Studies show that identifying fungi based on appearance alone is often unreliable without culture or PCR confirmation.
Take-home messages:
- Routine laboratory methods remain essential in clinical practice.
- MALDI-TOF and susceptibility testing are now standard in many centres.
- Microscopy alone is not sufficient for accurate identification.
Emerging and Experimental Approaches
Host DNA methylation diagnostics
A machine learning approach using host cell-free DNA methylation patterns showed potential for diagnosing Aspergillus infection.
New diagnostic targets
A review highlighted promising new biomarkers including siderophores and urinary glycans.
Take-home messages:
- New diagnostics are moving towards host-response and multi-omics approaches.
- These methods may improve early detection in the future.
- Most are still in research stages and not yet widely available.
Clinical Context and Diagnostic Challenges
Across all studies, a key theme is that fungal diagnostics are highly context-dependent.
- Imaging is often non-specific
- Molecular tests may detect colonisation
- Biomarkers can give false positives or negatives
Take-home messages:
- No single test can confirm or exclude fungal disease in all cases.
- Diagnosis requires combining clinical, radiological, and laboratory information.
- Interpretation is often as important as the test itself.
Common Questions
Are newer tests replacing older ones?
No—new tests are being added, not replacing traditional methods.
Why are fungal infections difficult to diagnose?
Because fungi can be present without causing disease, and tests detect different aspects of infection.
Are rapid tests always better?
They are faster, but not always more accurate in all situations.
When to Seek Medical Advice
Seek medical attention if you experience:
- Persistent breathlessness
- Unexplained fever
- Coughing up blood
- Worsening lung symptoms
If you have an existing lung condition such as chronic pulmonary aspergillosis or allergic bronchopulmonary aspergillosis,
any change in symptoms should be discussed with your clinical team.
References
- Standl L, Huber T, Bloos F, et al.
Diagnostic performance of beta-(1→3)-D-glucan, two Candida antigen, and five anti-Candida antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial.
J Clin Microbiol. 2026.
PMID: 42023876 - Salem-Bango Z, Njai MB, Tambajang Z, et al.
Prevalence of fungal infections in a patient cohort in The Gambia: multiplex quantitative PCR detection of Aspergillus spp., Histoplasma spp., and Pneumocystis jirovecii.
PLoS One. 2026.
PMID: 42030344 - Jang WS, Choe YL, Yoon SY, et al.
Development of a loop-mediated isothermal amplification (LAMP) assay for the screening of Candida auris.
PLoS One. 2026.
PMID: 42030301 - Hogan CA, Su LD, Laley J, et al.
Test performance of a commercial cryptococcal antigen lateral flow assay: a retrospective and prospective study at five Canadian sites.
J Clin Microbiol. 2026.
PMID: 42017896 - Vanbiervliet Y, Aerts R, Maessen L, et al.
Laboratory innovations to diagnose invasive mould infections—what is relevant, what is not?
Clin Microbiol Infect. 2026.
PMID: 41173342 - Zhang X, Li W, Wu H, et al.
Enhanced pathogen identification in fungal endophthalmitis by metagenomic next-generation sequencing: a retrospective clinical evaluation.
Sci Rep. 2026.
PMID: 42032049 - Toro P, Doxtader E, Mukhopadhyay S.
Accuracy of genus-level diagnosis of fungal organisms in lung specimens based on morphology alone: comparison with microbiology and PCR.
Int J Surg Pathol. 2026.
PMID: 41248033 - Gold JAW, Benedict K, Haass KA, et al.
Yeast identification, antifungal susceptibility testing, and Candida auris screening practices at acute care hospitals and long-term acute care hospitals, United States.
J Clin Microbiol. 2026.
PMID: 42007838 - Jabri B, Faouzi S, Bouzit A, et al.
A combined rapid phenotypic strategy for the identification of Candida albicans: performance evaluation against PCR.
Diagn Microbiol Infect Dis. 2026.
PMID: 41880733 - Chen Z, Gu Y, Xue C, et al.
Dual-target recombinase polymerase amplification-lateral flow strip (RPA-LFS) for rapid detection of Fusarium keratoplasticum in infectious keratitis.
Exp Eye Res. 2026.
PMID: 41651440